Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.

Mease PJ, Wei N, Fudman EJ, Kivitz AJ, Schechtman J, Trapp RG, Hobbs KF, Greenwald M, Hou A, Bookbinder SA, Graham GE, Wiesenhutter CW, Willis L, Ruderman EM, Forstot JZ, Maricic MJ, Dao KH, Pritchard CH, Fiske DN, Burch FX, Prupas HM, Anklesaria P, Heald AE.

J Rheumatol. 2010 Apr;37(4):692-703. doi: 10.3899/jrheum.090817. Epub 2009 Dec 23.

PMID:
20032102
2.

The low-throughput protein A adsorber: an immune modulatory device. Hypothesis for the mechanism of action in the treatment of rheumatoid arthritis.

Brunner J, Kern PM, Gaipl US, Munoz LE, Voll RE, Kalden JR, Wiesenhutter CW, Herrmann M.

Mod Rheumatol. 2005;15(1):9-18.

PMID:
17028816
3.

Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial.

Wiesenhutter CW, Boice JA, Ko A, Sheldon EA, Murphy FT, Wittmer BA, Aversano ML, Reicin AS; Protocol 071 Study Group.

Mayo Clin Proc. 2005 Apr;80(4):470-9.

PMID:
15819283
4.

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial.

Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY.

Arch Intern Med. 2002 Jun 10;162(11):1293-300.

PMID:
12038948
5.
6.

In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter's syndrome. Lack of response in other HLA-B27 positive individuals.

Brenner MB, Kobayashi S, Wiesenhutter CW, Huberman AK, Bales P, Yu DT.

Arthritis Rheum. 1984 Mar;27(3):250-7.

PMID:
6608353

Supplemental Content

Loading ...
Support Center